Holen Sie sich die Stockscreener-App
1.74
0.87%
0.015
Schlusskurs vom Vortag:
$1.725
Offen:
$1.71
24-Stunden-Volumen:
8,932
Relative Volume:
0.29
Marktkapitalisierung:
$69.49M
Einnahmen:
$1.88M
Nettoeinkommen (Verlust:
$-16.06M
KGV:
-8.7968
EPS:
-0.1978
Netto-Cashflow:
$-50.09M
1W Leistung:
+7.41%
1M Leistung:
+20.00%
6M Leistung:
-2.25%
1J Leistung:
+29.85%
1-Tages-Spanne:
$1.53
$1.75
1-Wochen-Bereich:
$1.52
$1.75
52-Wochen-Spanne:
$0.98
$3.44
Beyondspring Inc Stock (BYSI) Company Profile
Firmenname
Beyondspring Inc
Sektor
Branche
Telefon
646-528-4184
Adresse
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY
Compare BYSI vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BYSI
Beyondspring Inc
|
1.69 | 70.93M | 1.88M | -16.06M | -50.09M | -0.1978 |
VRTX
Vertex Pharmaceuticals Inc
|
433.89 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.12 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.85 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.40 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.62 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Beyondspring Inc Stock (BYSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-12-02 | Herabstufung | Jefferies | Buy → Hold |
| 2021-12-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-12-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-09-09 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-08-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-04-05 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-01-11 | Eingeleitet | BofA Securities | Buy |
| 2020-12-29 | Eingeleitet | Evercore ISI | Outperform |
| 2020-02-07 | Eingeleitet | Jefferies | Buy |
| 2020-01-10 | Eingeleitet | Nomura | Buy |
| 2019-12-03 | Eingeleitet | William Blair | Outperform |
| 2019-07-10 | Bestätigt | H.C. Wainwright | Buy |
| 2019-04-30 | Herabstufung | Maxim Group | Buy → Hold |
| 2018-10-25 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Beyondspring Inc Aktie (BYSI) Neueste Nachrichten
Here's Why We're A Bit Worried About BeyondSpring's (NASDAQ:BYSI) Cash Burn Situation - Yahoo Finance
BeyondSpring (NASDAQ:BYSI) Stock Passes Above 50 Day Moving Average – Here’s Why - Defense World
BYSI PE Ratio & Valuation, Is BYSI Overvalued - Intellectia AI
BeyondSpring Stock Crosses 50-Day Moving Average - National Today
BeyondSpring (NASDAQ:BYSI) Stock Crosses Above 50 Day Moving AverageShould You Sell? - MarketBeat
BeyondSpring (BYSI) director receives 22,165 stock options grant - Stock Titan
Director Delaney granted BYSI stock options under 2017 plan - Stock Titan
BeyondSpring (BYSI) director receives 21,730 options at $1.64 strike - Stock Titan
BeyondSpring (BYSI) awards CSO 17,840 stock options at $1.64 strike - Stock Titan
BeyondSpring (BYSI) CEO Huang Lan receives grant of 11,514 stock options - Stock Titan
BeyondSpring (BYSI) director Xu Sihai awarded 18,689 stock options at $1.64 - Stock Titan
BeyondSpring Inc. (BYSI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026 - Bitget
BeyondSpring lands April AACR slot for plinabulin-ADC cancer data - Stock Titan
BeyondSpring (NASDAQ:BYSI) Trading Down 0.6%Should You Sell? - MarketBeat
Layoff Watch: Can BeyondSpring Inc beat the S P 5002026 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn
Overcoming PD-1/L1 Resistance: Translational Insights with Plinabulin - marketscreener.com
BeyondSpring : Corporate Presentation - marketscreener.com
BeyondSpring Inc. 2025 Annual Report – Plinabulin Clinical Progress, SEED TPD Platform, and Strategic Collaborations with Eli Lilly & Eisai - Minichart
EV Market: How does BeyondSpring Inc perform in inflationary periodsWeekly Trade Summary & Growth Focused Stock Pick Reports - baoquankhu1.vn
BeyondSpring Inc. (BYSI) Reports FY2025 Earnings - AlphaStreet
BeyondSpring Files 2025 Annual Report on Form 10-K - Bitget
BeyondSpring 10-K: $0M Revenue, $(0.02) EPS, net loss $(14.22)M - TradingView
BeyondSpring (NASDAQ: BYSI) posts 2025 loss and warns it needs more funding - Stock Titan
BYSI: Net loss narrowed to $14.2M in 2025 as Plinabulin advanced in global NSCLC trials - TradingView
BeyondSpring Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
BeyondSpring Inc. Confirms Phase 3 Overall Survival Benefit for Plinabulin in NSCLC and Plans DUBLIN-4 Study - Quiver Quantitative
Jobs Data: How does BeyondSpring Inc compare to its peersTrade Analysis Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
BeyondSpring (NASDAQ: BYSI) narrows 2025 loss as Plinabulin Phase 3 data drive new trial - Stock Titan
Lung cancer drug shows survival gain as BeyondSpring readies new trial - Stock Titan
Wall Street Recap: Whats the RSI of BeyondSpring Inc stockPortfolio Return Summary & Reliable Price Action Trade Plans - baoquankhu1.vn
BeyondSpring (BYSI) Stock Analysis Report | Financials & Insights - Benzinga España
Buyback Watch: Will BeyondSpring Inc stock go up in YEAR2026 Breakouts & Fast Momentum Entry Tips - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Aug Mood: How does BeyondSpring Inc compare to its peersWatch List & Technical Entry and Exit Tips - baoquankhu1.vn
Institution Moves: How does BeyondSpring Inc compare to its peersPortfolio Gains Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Is BeyondSpring Inc stock influenced by commodity pricesJuly 2025 Summary & Community Verified Trade Signals - baoquankhu1.vn
BeyondSpring Stock Drops Below 50-Day Average - National Today
BeyondSpring (NASDAQ:BYSI) Stock Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
Travel Stocks: Whats the beta of BeyondSpring Inc stock2025 Top Gainers & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
XGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
BYSI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OPTX PE Ratio & Valuation, Is OPTX Overvalued - Intellectia AI
US Market Wrap: How does BeyondSpring Inc compare to its peersWeekly Earnings Recap & Technical Confirmation Trade Alerts - baoquankhu1.vn
BeyondSpring Shares Rise 2.4% - National Today
Will BeyondSpring Inc. benefit from rising consumer demand2025 Key Highlights & Weekly Chart Analysis and Trade Guides - mfd.ru
Will BeyondSpring Inc. outperform tech stocksOptions Play & Community Consensus Trade Signals - mfd.ru
Risk Recap: How does BeyondSpring Inc perform in inflationary periodsQuarterly Portfolio Report & Precise Buy Zone Identification - baoquankhu1.vn
Will BeyondSpring Inc. outperform during market ralliesJuly 2025 Reactions & Free Risk Controlled Daily Trade Plans - mfd.ru
Forecast Cut: What dividend growth rate does BeyondSpring Inc offerWeekly Investment Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Finanzdaten der Beyondspring Inc-Aktie (BYSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Beyondspring Inc-Aktie (BYSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Decheng Capital China Life Sci | 10% Owner |
Oct 17 '25 |
Sale |
1.76 |
45,513 |
80,103 |
1,518,893 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 13 '25 |
Sale |
1.70 |
107,361 |
182,514 |
1,696,659 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 14 '25 |
Sale |
1.65 |
28,495 |
47,017 |
1,668,164 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 15 '25 |
Sale |
1.65 |
17,960 |
29,634 |
1,650,204 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 08 '25 |
Sale |
1.77 |
7,507 |
13,287 |
1,810,389 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 09 '25 |
Sale |
1.81 |
3,979 |
7,202 |
1,806,410 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 10 '25 |
Sale |
1.77 |
2,390 |
4,230 |
1,804,020 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 06 '25 |
Sale |
1.78 |
17,500 |
31,150 |
1,819,996 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 07 '25 |
Sale |
1.79 |
2,100 |
3,759 |
1,817,896 |
| Decheng Capital China Life Sci | 10% Owner |
Oct 03 '25 |
Sale |
1.76 |
600 |
1,056 |
1,837,496 |
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):